“We are all functioning at a small fraction
of our capacity to live fully
in its total meaning
of loving, caring, creating and adventuring.
Consequently, the actualizing of our potential
can become the most exciting
adventure of our lifetime.”
– Herbert Otto
Good News and Hope from
NaturalNews click here for article

We were so enamored and captivated with what happened in this bird bath, that numerous photographs were taken.
Groundbreaking new research on the cancer-fighting potential of vitamin C has made the pages of the peer-reviewed journal Science Translational Medicine. A team of researchers from the University of Kansas reportedly tested the effects of vitamin C given in high doses intravenously on a group of human subjects and found that it effectively eradicates cancer cells while leaving healthy cells intact.

Note the unusual geometry and even spacing between the clusters of bubbles. Nature is full of fascinating wonder. And the most fascinating is YOU.
Building upon research pioneered by the late Linus Pauling, from Oregon State University who today is recognized as the world’s foremost proponent of therapeutic vitamin C, the new research involved injecting high doses of vitamin C into human ovarian cells. The tests were conducted in vitro in a lab, as well as directly in both mice and a group of 22 human subjects.

EACH bubble consisted of many other tiny bubbles! Perhaps YOU can explain this! Let us hear from you.
According to BBC News, the tests showed favorable results in all three models, as vitamin C effectively targeted the ovarian cancer cells while avoiding healthy cells. The benefits of high-dose vitamin C were also observed in conjunction with conventional chemotherapy treatments, which destroy all cells, both healthy and malignant, eventually leading to patient death.
“Patients are looking for safe and low-cost choices in their management of cancer,” stated Dr. Jeanne Drisko, a co-author of the study, to BBC News concerning the findings. “Intravenous vitamin C has that potential based on our basic science research and early clinical data.”
Researchers admit more human trials on intravenous vitamin C unlikely because drug companies cannot patent vitamins.
The next step for this type of research would typically involve applying these same parameters in a large-scale clinical human trial to see if they can be replicated and confirmed. While this new study is admittedly convincing on its own, the hurdles to gaining widespread acceptance of its findings include replicating them across a much larger human sample size.
But this may never actually take place. And the reason, says the research team, is that such trials require major funding that typically comes from pharmaceutical companies interested in developing a patented drug. Drug companies, in other words, are hardly interesting in promoting the medicinal benefits of natural substances like vitamin C, which stands to decimate the multibillion-dollar conventional cancer industry if word gets out about its benefits. [Now there is a truly sad commentary on our humanity.] By the way, studies also show inadequate vitamin C levels Boost the risk of the most deadly type of stroke by nearly fifty percent (50%).
“Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies,” says Qi Chen, lead author of the new study. “We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C.”
Perhaps, my friends, Bob Dylan expresses it best:
from “Blowing In The Wind”
“How many times must a man look up
Before he can see the sky?
Yes, ‘n’ how many ears must one man have
Before he can hear people cry?
Yes, ‘n’ how many deaths will it take till he knows
That too many people have died?
Pretending he just doesn’t see?
The answer, my friend, is blowin’ in the wind
The answer is blowin’ in the wind.”
The conventional medical industry’s response to these and similar findings over the years has been nothing short of derisive, which is to be expected. Having to rationalize decades of ushering cancer patients through the gauntlet of chemotherapy, radiation and surgery — with dismal results — while ignoring natural cancer-fighting alternatives like vitamin C is a hard pill to swallow for this powerful, high-profit industry, which would rather everyone ignore such findings than think critically about them.
“[A]scorbate is processed by the body in different ways when administered orally versus intravenously,” writes Heidi Ledford for Nature about this commonly misunderstood variance. The medical-industrial complex, it turns out, intentionally corrupts the conversation on vitamin C by convoluting the distinct effects of these very different delivery routes.
“Oral doses [of vitamin C] act as antioxidants, protecting cells from damage caused by reactive compounds that contain oxygen. But vitamin C given intravenously can have the opposite effect by promoting the formation of one of those compounds: hydrogen peroxide. Cancer cells are particularly susceptible to damage by such reactive oxygen-containing compounds.”
Sources for this article include: